Skip to main content
. 2013 Aug 2;69A(3):354–362. doi: 10.1093/gerona/glt114

Table 2.

Fixed Effects for Multilevel Models of Change in Fast Walking Speed Before Death or End of Follow-up

Fixed Effects Model 1 Model 2*
Estimate (95% CI) p Estimate (95% CI) p
Intercept 1.551 (1.537, 1.567) <.0001 1.581 (1.560, 1.603) <.0001
Sex (women vs men) −0.241 (−0.257, −0.226) <.0001 −0.192 (−0.215, −0.170) <.0001
Age (centered at 80 y), per 10-y increment) −0.152 (−0.174, −0.131) <.0001 −0.152 (−0.174, −0.131) <.0001
Vital status (dead vs alive) −0.090 (−0.113, −0.067) <.0001 −0.074 (−0.097, −0.051) <.0001
Time (annual change) −0.021 (−0.022, −0.020) <.0001 −0.020 (−0.022, −0.018) <.0001
Time × age −0.006 (−0.009, −0.002) .002 −0.006 (−0.010, −0.003) .0004
Time × vital status −0.009 (−0.013, −0.005) <.0001 −0.009 (−0.014, −0.005) <.0001

Notes: CI = confidence interval. *Adjusted for sex, age, vital status, education, height, smoking ≥20 pack-years, homocysteine, time, time × age, time × vital status, time × education, time × height, time × smoking ≥20 pack-years, time × homocysteine, time-dependent variables (body mass index, physical activity, coronary/peripheral artery disease, antihypertensive drugs, diabetes, lipid-lowering drugs, mini-mental state examination score, psychotropic drugs).

In model 1, the intercept corresponds to the average walking speed at the end of follow-up for men alive and aged 80 y. In model 2, the intercept corresponds to the average walking speed at the end of follow-up for men alive and aged 80 y, with primary school level, body mass index = 25 kg/m2, height = 165 cm, physically active, smoking <20 pack-years, no health conditions, mini-mental state examination = 30, homocysteine = 14 µmol/L.